Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis (Q38294339)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 1995
edit
Language Label Description Also known as
English
Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis
scientific article published on June 1995

    Statements

    Immunospecific reduction of antioligonucleotide antibody-forming cells with a tetrakis-oligonucleotide conjugate (LJP 394), a therapeutic candidate for the treatment of lupus nephritis (English)
    D S Jones
    P A Barstad
    M J Feild
    J P Hachmann
    M S Hayag
    K W Hill
    G M Iverson
    D A Livingston
    M S Palanki
    A R Tibbetts
    1 June 1995
    2138-2144

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit